OIG faults OptionCare over rebate
OIG examines OptionCare's vendor rebates
Pioglitazone study shows reduction in death risk
A pioglitazone (Actos, Takeda) study from Cleveland Clinic shows a reduction in stroke, myocardial infarction and death
CMS proposal wastes pharmacists' time, ASHP charges
ASHP calls proposal "burdensome"
Benefits still outweigh risks for Trasylol
FDA advisory committees vote to keep Trasylol on the market
Ortho Biotech supports FDA decision on ESA product label changes
FDA: No label changes needed for ESA product
New lung cancer guide nixes vitamin and supplement use
New lung cancer guidelines are released from the American College of Chest Physicians.
Hospital patients are now sicker but survive longer
Patient survival rates improve
Rocephin PI updated to reflect calcium interaction
Ceftriaxone prescribing information updated to warn of calcium interaction
Abbott to patients: Check blood glucose display screens
Abbott notifies patients to check blood glucose display screens.
CMS updates mailings guide
CMS has released an updated guide to mailings sent to Medicare Part D beneficiaries by prescription drug plans, CMS, or the Social Security Administration.
AmeriHealth promotes generic drug usage with free samples
AmeriHealth offers free one-month generic samples
Wholesaler opens new high-tech center
AmerisourceBergen Technology Group opens new facility in Buffalo Grove, Ill.
Bodee recalls Zencore Tabs
Bodee's Zencore Tabs recalled
Sanofi-Aventis settles AWP suit for $190 million
Sanofi-Aventis settles case alleging the company inflated the average wholesale price to boost profits on its Anzemet.
ADE number doubles in seven years
The number of adverse drug events reported to the FDA has doubled in the past seven years.
FDA reacts to possible carcinogen found in Viracept
Nelfinavir mesylate is found to contain ethyl methanesulfonate.
N.J. pharmacy develops tech-training program
New Jersey officials have approved the technician-training program developed by Wedgewood Pharmacy, a veterinary compounding pharmacy.
UCSF program focuses on drug development, regulation
University of California is offering a new two-year postgraduate program in drug development and regulation.
Survey: Government regulation impacts most pain care practices
Ninety percent of polled pain care professionals say government regulation impacts their practices.
Patient sues hospital for fumbled handoff
Poor communication between a health-system's two facilities caused a newborn to be separated from its mother, who has filed a lawsuit as a result.
CMS rejects petition to strengthen genetic testing
CMS rejects petition to improve standards for genetic testing.
Trade group says vitamin D research could confuse Americans
Natural Products Association believes new vitamin D research could confuse Americans, especially the elderly.
HealthPartners redesigns prescription labels
HealthPartners pharmacy has redesigned its Rx labels for greater clarity.
Specialty pharmacy and drug company expand access to fertility drug
DesignRx and Columbia expand access to progesterone gel for uninsured.
Senate urges CMS to reconsider decision on ESA coverage
Senate asks CMS to reconsider ESA coverage decision
New York City hospital data now publicly accessible
Data on infection and death rates at New York City's hospitals is being publicly released
Hospira chief calls for biogeneric approval pathway
With biologic costs zooming, it's time for biogenerics to be approved, says Hospira CEO.
Employer group gives stamp of approval to 13 PBMs
An employer group finds that 13 pharmacy benefit managers are willing to operate transparently in their drug contracting dealings with their clients.
New report card shows how hospitals are performing
Healthcare report card provides data on quality of hospital care, mortality rates at hospitals in New York and New Jersey.
Investigational antipsychotic offers new MOA
Investigational drug may provide new approach to treating schizophrenia.
